Metropolis Healthcare acquires Core Diagnostics

Metropolis Healthcare has acquired Core Diagnostics for Rs 246.83 crore. The transaction includes 55% financing in cash and 45% through an equity swap.

Core Diagnostics operates in 200 cities in India. The company has a NABL- and CAP-accredited laboratory in Gurugram, a regional reference lab in Hyderabad, and seven satellite labs. The acquisition will enhance Metropolis Healthcare’s advanced cancer testing capabilities and strengthen its northern and eastern India footprint.
MB Bureau